H. Lundbeck AS - Company Profile
Powered by
All the data and insights you need on H. Lundbeck AS in one report.
$295
- Save hours of research time and resources with
our up-to-date H. Lundbeck AS Strategy Report
- Understand H. Lundbeck AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on H. Lundbeck AS patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4058431A1 | Application | KRISTALLINE FORMEN EINES MAGL-INHIBITORS | A61K31/495; A61P25/00; C07B2200/13; C07D241/04 | September 21, 2022 |
US20220280455A1 | Application | ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE IN EPILEPSY OR SEIZURES | A61K31/165 | September 08, 2022 |
JP2022539197A | Application | NMDA受容体の調節因子 | A61K31/437; A61P25/08; A61P25/24; B60W2510/20; B60W30/06; B60W60/001; B62D15/0285; C07B2200/07; C07D495/04 | September 07, 2022 |
US11434222B2 | Grant | MAGL inhibitors | A61P25/04; A61P25/08; C07D221/20; C07D401/12; C07D401/14; C07D405/12; C07D413/12; C07D417/12; C07D471/04; C07D487/04; C07F9/65583 | September 06, 2022 |
US11434199B2 | Grant | Alcohol derivatives as KV7 potassium channel openers | A61P25/04; A61P25/06; A61P25/08; A61P25/18; A61P25/22; A61P25/24; A61P25/28; C07B2200/07; C07C235/06; C07C235/08; C07C235/26; C07C2601/02; C07C2601/04 | September 06, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer